Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Rhabdophis tigrinus (Yamakagashi) Bites in Japan Over the Last 50 Years

A Retrospective Survey

Bibliographic Data

ID22085170
AuthorsToru Hifumi (0000-0003-3581-0890, St. Luke's International Hospital, corresponding author), Atsushi Sakai (0000-0002-3996-8022, Japan Snake Institute), Akihiko Yamamoto (0000-0001-9400-1060, National Institute of Infectious Diseases), Kazunori Morokuma (Kumamoto Health Science University), Norio Otani (0000-0001-7122-5555, St. Luke's International Hospital), Motohide Takahashi (0009-0000-8404-4913, Kumamoto Health Science University), Manabu Ato (0000-0002-3178-2645, National Institute of Infectious Diseases)
Year2022
Volume9
Pages775458-775458
Publication date2022-01-10
Open AccessYes
TypeARTICLE
VenueFrontiers in Public Health (JOURNAL)
Journal identifiersISSN: 2296-2565 • E-ISSN: 2296-2565
PublisherFrontiers Media SA (PUBLISHER • CH)
DOI10.3389/fpubh.2021.775458
PMID35083190
OpenAlexW4206364743
LanguageEN
References cited16

Introduction: Rhabdophis snakes, which include 27 species, are rear-fanged venomous snakes that are widely distributed from India to East Asia and Russia. Severe envenomation by R. tigrinus (Yamakagashi snake) in Japan and R. subminiatus in Southeast Asia has been reported. The epidemiology of R. tigrinus bites, such as geographical features, the incidence, and changes in the number of bites over time have not been comprehensively examined. Hence, we intended to clarify the epidemiological features of R. tigrinus bites through a careful review of scientific data over the last 50 years in Japan. Methods: Patient records of R. tigrinus bites between 1971 and 2020 at the Japan Snake Institute were examined retrospectively. The following were ascertained: patient characteristics, clinical symptoms, laboratory data, treatment-related factors, and hospital mortality. These variables were compared in the antivenom and the without-antivenom groups. Results: Over the 50-year study period, 43 R. tigrinus bites, including five fatal cases, were encountered. Severe cases of R. tigrinus bites have been treated with antivenom since 1985; however, fatalities occurred in 2006 and 2020. R. tigrinus bite cases have been well-distributed in the western part of Japan since 2000. The mortality rate in the antivenom group was significantly lower in the patient group that was not administered the antivenom (0 vs. 23.8%, p = 0.048). Conclusion: This study clarified the epidemiology of R. tigrinus bites in Japan over a 50-year period. Almost all severe cases of R. tigrinus bites have been treated with the antivenom in the current situation, and fatalities occurred in cases not treated with the antivenom. It is important to diagnose R. tigrinus bites in the early phase of the clinical course. The antivenom, the definitive treatment for R. tigrinus bites, is an unapproved drug. Hence, approval needs to be obtained for the drug

Antivenom · Biology · Envenomation · Retrospective cohort study · Venom · Bioactive Natural Diterpenoids Research · Medicine · Rabies epidemiology and control · Venomous Animal Envenomation and Studies · Ecology · Epidemiology · Internal Medicine · Surgery

Highly citedNo

Tools

Open DOIOpen Access
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae